1. Home
  2. Stocks
  3. ASX
  4. RAC

Logo of Racura Oncology (ASX:RAC)Latest Racura Oncology (ASX:RAC) News

Page 5
Page 5 of 5
Race Oncology Advances Phase 1 Trial, Boosts Cash to $18.8M with New Board Appointments

Race Oncology Nears Phase 1 Trial Start with $18.8M Cash Boost

Race Oncology has advanced its Phase 1 clinical trial for RC220, submitting ethics approvals and bolstering its cash reserves to $18.78 million following a $5.25 million R&D tax incentive.
Victor Sage
31 Jan 2025